T cells are stimulated by the engagement of antigen, cytokine, pathogen, and hormone receptors. While research performed over many years has focused on deciphering the molecular components of these pathways, recent data underscore the importance of the metabolic environment in conditioning responses to receptor engagement. The ability of T cells to undergo a massive proliferation and cytokine secretion in response to receptor signals requires alterations to their bioenergetic homeostasis, allowing them to meet new energetic and biosynthetic demands. The metabolic reprogramming of activated T cells is regulated not only by changes in intracellular nutrient uptake and utilization but also by nutrient and oxygen concentrations in the extracellular environment. Notably, the extracellular environment can be profoundly altered by pathological conditions such as infections and tumors, thereby perturbing the metabolism and function of antigen-specific T lymphocytes. This review highlights the interplay between diverse metabolic networks and the transcriptional/epigenetic states that condition T-cell differentiation, comparing the metabolic features of T lymphocytes with other immune cells. We further address recent discoveries in the metabolic pathways that govern T-cell function in physiological and pathological conditions. Keywords: differentiation; effector functions; epigenetics; immune function; metabolism; nutrients; oxygen; T cells; transcription factors
The potential of immune cells to respond to infections, foreign antigens, and even auto-antigens requires the induction of metabolic pathways that support their proliferation and activation. Immune cell responsiveness depends on the generation of energy in the form of ATP but recent work has also highlighted the importance of metabolite pathways in bioenergeticindependent processes including: (a) nucleic acid, amino acid, and phospholipid synthesis; (b) de novo lipogenesis; and (c) production of reducing equivalents to maintain the redox state of the cell. Moreover, we have learned that a wide range of diverse fuels as well as their utilization in different pathways govern immune cell function as well as plasticity; for example, metabolic alterations regulate the 'choice' between effector and regulatory T (Treg) cell fates as well as between IFNc-secreting M1 and IL4-secreting M2 macrophages (reviewed in ref. [1] [2] [3] [4] ). The metabolism of a cell conditions its response to receptor and cytokine signals, controlling transcription factor networks Abbreviations aKG, alpha-ketoglutarate; AMPK, AMP-activated protein kinase; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GCN2, general control nonrepressed 2; GlcNAc, N-acetylglucosamine; HDACs, histone deacetylases; HIF1a, hypoxia-inducible factor 1a; IDO, indoleamine 2,3-dioxygenase 1; Kyn, kynurenine; mTOR, mammalian target of rapamycin; OXPHOS, oxidative phosphorylation; R-2HG, R-2-hydroxyglutarate; TCA, tricarboxylic acid; Teff, T effector; Treg, T regulatory; Trp, tryptophan. and the epigenetic landscape. In this review, we focus on recent discoveries revealing the regulation of T lymphocytes in the context of different metabolite resources and activation of metabolic pathways, specifically addressing the metabolic regulation of transcriptional pathways and epigenetic modifications (Fig. 1) . The composition of the extracellular environment also fluctuates in pathological conditions as a consequence of metabolite, electrolyte, proton, and oxygen concentrations, among others. Here, we highlight the importance of pathological extracellular environments, generated as a response to tumor growth or infection, in the regulation of T-cell plasticity and function.
Interplay between nutrients and downstream effectors in T-cell differentiation and function
The metabolic needs of activated immune cells are generally secured by augmented nutrient entry and changes in the utilization of those nutrients. Cell surface upregulation of metabolite transporters is a rate-limiting step in nutrient entry and indeed, the upregulation of glucose, glutamine, and neutral amino acid transporters are a sine qua non for optimal T-cell proliferation and effector function [5] [6] [7] [8] [9] [10] [11] [12] [13] . The phenotypic alterations that occur in activated T lymphocytes are conditioned by the range of accessible metabolites and the means in which they are metabolized.
Upon TCR stimulation, naive T cells undergo a metabolic reprogramming favoring aerobic glycolysis, wherein glucose is converted to lactate, as compared to glucose catabolism via the mitochondrial tricarboxylic acid (TCA) cycle and oxidative phosphorylation (OXPHOS). Glycolysis is less efficient than OXPHOS in energy production (2 net ATPs as compared to 32-34 ATPs), but it is more efficient in producing the carbons and electrons (NADH/NADPH) that are required for production of macromolecular precursors; these include acetyl co-A for fatty acids, glycolytic intermediates for amino acids and ribose for nucleotides, promoting a rapid growth and proliferation of immune cells [2, 4] . Furthermore, under conditions of high glucose flux, the shunting of glucose through the pentose phosphate pathway, leading to the synthesis of five-carbon sugars used for nucleotide The effects of the metabolic environment are conducted in the cell via different sensors. These inputs are then transcribed into changes in the transcriptional, epigenetic, redox, and energy status of a cell. The major players in these processes are indicated here: (a) Molecules such as mTOR integrate nutrient-sensing pathways while AMPK and GCN2 respond to the energy homeostasis of the cell and integrate stress responses; (b) Transcription factors such as HIF and Myc not only confer metabolic advantages to cancer cells but also regulate T cell effector function; (c) Epigenetic-metabolomic crosstalk governs T-cell fate via changes in methylation, acetylation, and succinylation among others; production of NAPDH through the pentose phosphate pathway favors macromolecular biosynthesis, the ratio of oxidized (GSSG) to reduced glutathione (GSH) serves as a marker of the redox homeostasis of the cell and NAD+ regeneration through mitochondrial respiration contributes to multiple levels of regulation in T lymphocytes including the control of T-cell inflammation [4, 15] . Energy transfer within the cell is mediated by nucleotides with the most important being ATP and GTP.
biosynthesis, results in an increased generation of the key intracellular reductant NADPH [14] (Fig. 1) .
While T cell activation results in a massive upregulation of glycolysis, OXPHOS is also critical for T cell function. Indeed, NAD+ regeneration through mitochondrial respiration improves T-cell lysosomal function and reduces inflammation [15] . The level of OXPHOS in T lymphocytes is modulated by the presence of amino acids. For example, arginine uptake results in a shift in metabolism from a glycolytic to OXPHOS program and this change has functional consequences, increasing the generation of central memory cells [10] . Furthermore, as outlined below, specific lymphocyte subsets exhibit differences in the utilization of nutrients as energy sources [16] . Glucose and glutamine are also utilized in the hexosamine pathway, producing uridine diphosphate N-acetylglucosamine (GlcNAc), a substrate for glycosyltransferases that catalyze post-translational O-GlcNAcylation. Notably, this glycosylation of serine/threonine residues by O-GlcNAC is required for T-cell activation [17] [18] [19] while a high-fat diet increases O-GlcNaC, priming CD4+ effector cells and potentially increasing susceptibility to autoimmune diseases [20] .
The importance of mitochondrial function in T-cell stimulation is underlined by the finding that within 15 min after TCR stimulation, mitochondrial ROS are generated, creating a positive feedback loop for TCR signaling [21, 22] . Indeed, fueling mitochondrial ROS production is a prerequisite for antigen-specific T-cell expansion [23] and mitochondria contribute to T-cell activation [23] [24] [25] [40] . Although the mechanisms that contribute to regulating glycolysis are complex, the mammalian target of rapamycin (mTOR) signaling pathways plays a critical role. mTOR is a serine/threonine protein kinase that integrates environmental cues from nutrients, growth factors, and stress signals into an 'optimal' cellular response that is mediated via two complexes, mTORC1 and mTORC2 [13, [41] [42] [43] . Indeed, mTOR signaling complexes show specificity in immune cell regulation; in the absence of mTORC1 but not mTORC2, Th17 cell differentiation is abrogated [44] . Furthermore, mTORC1 is required for Th1 and Th17 differentiation as well as CD8 cytolytic activity while mTORC2 promotes Th2 differentiation [44] [45] [46] [47] [48] .
Mammalian target of rapamycin activity is directly regulated by the AMP-activated protein kinase (AMPK) complex, a sensor of nutrient stress, in cooperation with the stress-activated kinase general control nonrepressed 2 (GCN2) (reviewed in ref. [49, 50] . AMPK is transiently upregulated on mature T cells by antigen receptor engagement [51] and regulates glycolysis and cytokine secretion [52] . Under conditions of glucose deprivation, AMPK directly inhibits mTOR signaling, resulting in changes in nutrient utilization (toward glutamine) and long-term memory CD8 T-cell generation and survival [53, 54] . Moreover, AMPK activity in memory CD8 T cells (at the expense of mTOR activation) promotes the mitochondrial uptake of fatty acids and their oxidation [28, 29] . Thus, AMPK activity results in a decreased dependence on glucose metabolism, contrasting with the glycolytic metabolism of effector cells.
Mammalian target of rapamycin signaling is mediated by numerous transcription factors but among the myriad of factors, c-Myc and hypoxia-inducible factor 1a (HIF1a) are probably the most critical [55-57] (Fig. 1 ). c-Myc directly regulates glutamine utilization within the cell by upregulating the expression of the rate-limiting glutaminase I enzyme that catalyzes the conversion of glutamine to glutamate [13, 58, 59] . HIF1a regulates Th1/Th17 effector differentiation and B-cell antibody production via the induction of the Glut1 glucose transporter as well as glycolytic enzymes [35, 37, 40, 44, 60] . It can also bind directly to the IFNG promoter, enhancing its expression [61] . Intriguingly, HIF1a has been reported to both positively [62, 63] and negatively [37, 61, 64] impact Foxp3 expression in Tregs. In support of a negative role for Foxp3 in regulating an mTOR-HIF1a-cMyc axis, it is notable that Foxp3 can suppress Myc expression and downstream glycolysis in Tregs, allowing them to function in lowglucose environments [65] . Furthermore, we and others have shown that Treg, but not Teff, generation is maintained under conditions where glucose, glutamine, and leucine transport are limiting [9, 12, [66] [67] [68] . Decreased nutrient entry inhibits mTOR activity and indeed, genetic abrogation of mTOR signaling promotes the generation and function of Tregs while blocking the generation of Teff [69] [70] [71] . Conversely, activation of mTOR blocks Treg differentiation and function [72] [73] [74] (Fig. 2) . The importance of suppressed mTOR function in inhibiting inflammation is also revealed in the macrophage system; inhibition of mTOR enhances the polarization of anti-inflammatory M2 polarization and decreases IFNc secretion by LPSstimulated M1 macrophages [75] [76] [77] . Thus, under physiological conditions, immune cell function is critically regulated by mTOR signaling pathways with limiting nutrient resources levels fostering an anti-inflammatory environment mediated by increased Treg and M2 macrophage function.
Regulation of T-cell function by metabolite-mediated epigenetic changes
Epigenetic modifications, including DNA methylation and acetylation as well as histone marks, have been shown to play an important role in immune cell differentiation and function. Deletion of the JMJD2 and UTX histone H3 lysine 27 trimethylation (H3K27Me3) dimethylases inhibit terminal thymocyte development [78] , while JMJD3 deletion attenuates Th1 and Treg differentiation, promoting polarization to a Th2 or Th17 fate and decreasing the expression of inflammatory genes in LPS-stimulated macrophages [79] [80] [81] . The JMJD2 enzyme has also been linked with IL17 production [82] . Furthermore, TET family deoxygenases play multiple roles in T-cell effector function-increasing IL17/IFNc, stabilizing the Foxp3 transcription factor in Treg cells, and promoting expansion of iNKT cells [83] [84] [85] [86] [87] . While these types of postnatal epigenetic modifications in immune cells were once thought to be completely independent of the cell's metabolic status, it is now clear that these two processes are intricately related. Within the innate immune system, trained immunity, the long-term memory that is associated with an epigenetic reprogramming at the level of histone H3 methylation, has recently been shown to be regulated by mTOR/HIF1a-stimulated glycolysis [88] . Furthermore, expression of the JHDM1D histone demethylase increases markedly upon long-term nutrient starvation [89] and both JMJD and TET demethylases require the alpha-ketoglutarate (aKG) metabolite as a cofactor [90, 91] . Thus, alterations in citric acid cycle enzymes that result in either the accumulation of succinate or fumarate or reduction of aKG to R-2-hydroxyglutarate (R-2HG)-inhibiting aKG-dependent demethylases-will alter the cell's epigenetic state [92] [93] [94] [95] [96] . Succinate can also independently alter the epigenetic state of a cell via succinylation [97] , exacerbating the effects of R-2HG [94] .
In M1 monocytes, metabolic constraints that increase succinate levels result in an inhibition of the activity of aKG-dependent prolyl hydroxylases that target HIF1a for proteosomal degradation [98, 99] . Thus, the presence of succinate leads to a stabilization of HIF and this has significant functional consequences for the M1 macrophage, enhancing IL1b production [100, 101] . Conversely, aKG promotes M2 macrophage differentiation [102] as well as Th1 differentiation in glutamine-deprived conditions [66] . Furthermore, the aKG/succinate ratio modulates stem cell differentiation potential [103, 104] . Another enantiomer of 2-HG, S-2-hydroxyglutarate, accumulates in T lymphocytes following physiological TCR engagement and its effects on demethylation and stabilization of HIF1a have been shown to enhance CD8 T-cell proliferation and antitumor function [105] . Thus, further research will undoubtedly uncover additional epigenetic networks via which the balance between succinate, fumarate, aKG, and 2-HG regulate immune cell function. The changes in the cell that occur as a result of these metabolites extend far beyond alterations in ATP production, altering the cell's epigenetic landscape.
Histone acetylation is a critical epigenetic modification that regulates immune cell function. Acetylation is regulated by multiple metabolites including acetyl-coA and acetate, produced via glycolysis and the fermentation of carbohydrates in the intestine by gut microbiota (reviewed in ref. [106] ). Notably, decreased glycolysis has recently been shown to lead to lower levels of acetyl-coA and subsequent histone acetylation, resulting in a loss of stem cell pluripotency [107] as well as decreased IFNc transcription in CD4 T cells [108] . Conversely, hyperacetylation in CD8 T cells is associated with an active state of the IFNG promoter [109] . There is also a complex interplay between glycolysis, IFNc and expression of HIF1a; the glycolytic enzyme GAPDH not only inhibits IFNc production by binding to the 3 0 UTR [38] but similarly negatively regulates HIF1a expression [110] . Thus, it will be important for future studies to determine the relative contributions of glycolysis-linked acetylation of the IFNG promoter and GAPDH-mediated binding to HIF1a and IFNc RNAs in the regulation of IFNc expression. The level of histone acetylation is also regulated by histone deacetylases (HDACs) with the family of sirtuin HDACs (Sirt) playing a critical role. Sirts are themselves directly regulated by the metabolic status of the cell; their activity is directly dependent on intracellular NAD+ levels [111] . Studies on the effects of Sirt1 in T lymphocytes have already revealed an impressive complexity; the absence of Sirt1 attenuates T-cell signaling and effector function [112] [113] [114] [115] [116] while deacetylation of RORct and Foxp3 promote Th17 differentiation [53] at the expense of Treg generation [117] [118] [119] , respectively. However, pharmacological Sirt1 activation inhibits Th17 differentiation [120] but increases IFNc secretion [121] . Irrespective of the precise effects of Sirt1 in T lymphocytes, the ensemble of these studies point to the importance of metabolite-regulated deacetylation in Teff differentiation and function.
Metabolic alterations in pathological conditions: effects on lymphocyte responsiveness
When individuals are affronted by a tumor or infection, the initiation of an immune response is generally extremely advantageous. However, the ability of immune cells to optimally respond to these insults is often negatively modulated by their metabolite environment, an environment that is conditioned by nutrient composition, 'waste' products, oxygen concentration, pH, and physical forces, among others. The dysregulated growth of cancer cells can directly influence the extracellular environment and multiple studies now strongly suggest that the metabolic phenotype of the tumor governs the ensuing immune response (reviewed in ref. [122, 123] ). In the context of several solid tumors including hepatocellular carcinomas and stomach/colon tumors, quantitative metabolome profiling has revealed decreased intratumoral concentrations of glucose and glutamine [124, 125] . Nutrient deprivation is associated with mitochondrial fusion and inhibition of autophagy [126] , processes that will alter the function of intratumoral T lymphocytes [33] . Moreover, tumor-infiltrating T cells demonstrate a loss of mitochondrial function due to decreased expression of PPAR-gamma coactivator 1a (PGC1a), a key factor in mitochondrial biogenesis [127] . Similarly, following CMV infection, decreased PGC1a in CD8 T cells results in mitochondrial dysfunction and exhaustion [128] . Notably, the competitiveness of T cells within the tumor environment may be enhanced by low mitochondrial function; adoptively transferred T cells with low mitochondrial membrane potential allow the identification of cells with optimal in vivo persistence and antitumor activity [129] .
Kynurenine Lactate
Competition of T cells and tumor cells for limiting amounts of glucose can lead to a decreased glycolysis in the former, resulting in a subsequent inhibition of T-cell cytolytic and effector function [38, 67, 130] . A metabolic checkpoint in glycolysis, phosphoenolpyruvate, has been identified as a key factor in the regulation of calcium flux and NFAT (nuclear factor of activated T cells) activity in T lymphocytes [131] . Furthermore, aerobic glycolysis promotes Th17 generation by starving the hexosamine pathway; when glycolysis is attenuated, reduced levels of GlcNAc promote a switch from a Th17 to an iTreg fate [65] . Bacteria and viruses such as Staphylococcus aureus and Hepatitis C, respectively, also generate glucose-limiting conditions, promoting adaptation via a metabolic reprogramming [132, 133] . Indeed, in the context of influenza infection, nutrient supplementation, and specifically glucose utilization, is necessary to protect against mortality [134] . Nevertheless, the competition for nutrients in the 'fight' against cancer and infections is clearly complex; nutrient restriction has been found to sensitize cancer cells to cytotoxic therapies and protect mice from the deleterious effects of bacterial sepsis [134, 135] . Thus, future research will be necessary to optimally define the role of diet and nutrients in regulating the body's responses to specific types of cancers, infections, and autoimmune conditions.
Competition for amino acids is also critical for Tcell function; decreases in glutamine, arginine, and leucine, among others, severely impact on the potential of na€ ıve T cells to differentiate into Teff cells [5-13, 66, 136] . In the absence of glucose and glutamine, T lymphocytes are biased toward a Treg cell fate [66, 136] . Unlike Teff cells, Foxp3+ Treg cells are capable of surviving in a low-glucose environment [35, 65] . Amino acid uptake by macrophages or their production of arginase can also serve to decrease amino acid availability for T lymphocytes [137, 138] .
'Waste' products within a tumor site or infection will also modulate immune responsiveness. The major metabolite, initially thought to function solely as a 'waste' product, is lactate. Lactate produced by aerobic glycolysis in tumor cells can be transported into T cells via monocarboxylate transporters [139] . Glycolysis and lactate production are regulated by pH as both phosphofructokinase and lactate dehydrogenase activities increase at alkaline pH, due at least in part to post-translational deprotonation (reviewed in ref. [140] ). Lactate has been found to decrease cytolytic CD8 T-cell function and T-cell motility [141] [142] [143] . Furthermore, lactate decreases NK cell cytotoxic function [144, 145] as well as the antigen presentation potential and differentiation of dendritic cells [146] . Lactate also functions to actively promote anti-inflammatory responses; unlike Teff cells, Tregs are relatively resistant to lactate. The Foxp3 transcription factor was found to mediate this resistance by inhibiting Myc activity and glycolysis [65] (Fig. 2) . Furthermore, lactate promotes the polarization and growth of immunosuppressive cells including M2 macrophages and myeloid-derived suppressor cells [137, 144, 145] . In light of these data, it is interesting to note that high lactate dehydrogenase levels correlate with a poor prognosis in several different types of tumors [147] [148] [149] [150] .
The degradation of tryptophan (Trp) results in the generation of a key metabolite in T-cell function, kynurenine (Kyn). This process is catalyzed by indoleamine 2,3-dioxygenase 1 (IDO), an enzyme that is upregulated in many cancers and correlates with a poor prognosis [151] [152] [153] [154] . High IDO levels result in the depletion of Trp in the tumor microenvironment and furthermore, Kyn promotes Treg polarization by activation of its downstream effector, the metabolic stress-sensing protein kinase GCN2 [155, 156] . In this regard, it is notable that Kyn is a ligand for the aryl hydrocarbon receptor that promotes Treg generation (for a review see [157] ). Trp depletion also attenuates Th1 proliferation but does not affect Th2 or Th17 subsets, highlighting metabolic differences between these subsets [158] (Fig. 2) . Finally, from a clinical perspective, IDO inhibitors show promising results in preclinical tumor models [155, 159, 160] and most significantly, the combined utilization of the IDO inhibitor indoximod with a PD-1 checkpoint inhibitor (pembrolizumab) has just been reported to result in a remarkable 52% overall response rate in patients with advanced melanoma [161] .
The immune response is also regulated by electrolytes such as sodium chloride, increasing T follicular helper and Th17 responses while decreasing Treg suppression and inflammation [162] [163] [164] . In contrast, extracellular potassium, increased by tumor necrosis, attenuates mTOR signaling and Teff function [165] . On another level, the antimicrobial metabolite itaconate, synthesized by the product of the immunoresponsive gene 1 (Irg1), cis-aconitate decarboxylase, regulates cytokine secretion by proinflammatory macrophages. Briefly, TCA cycle-generated citrate is used for the synthesis of itaconate which then acts as an inhibitor of succinate dehydrogenase, resulting in succinate accumulation and enhanced M1 immune reactivity [166] [167] [168] . Extracellular ATP also regulates the immune response upon its metabolism to adenosine via the CD39/CD73 ectoenzymes. Activation of the CD39/adenosine axis correlates with a higher Treg suppressor activity and lower CD4+ counts in HIV-1+ patients [169, 170] (Fig. 2) .
Finally, it is important to note that the extracellular environment is not solely defined by its composition in metabolites, electrolytes, protons or oxygen but also by physical parameters such as hydrostatic pressure, shear stress, and tension forces [171] . Tumors generally exhibit an increased stiffness [172] and a recent study has elegantly shown the critical nature of stiffness in the cell cycle progression, metabolism, and cytokine secretion profile of TCR-stimulated T cells [173] . Thus, the ensemble of these data point to the importance of the global extracellular environment in regulating the metabolic status of immune cells in both physiological and pathological conditions.
Conclusion
The integration of data emerging from research on metabolite-regulated transcriptional, epigenetic, and energy networks will bring novel insights to our understanding of T lineage differentiation and function. This is particularly crucial for furthering our understanding of pathological situations where stresses such as infections and tumors can alter the metabolite levels that are available for infiltrating immune cells. While much recent research has focused on the importance of nutrients-including amino acids-in effector function, future studies will allow us to ascertain the role(s) of electrolytes, minerals, and pH in immune regulation. Evaluation of the metabolic crosstalk between immune cells and their complex microenvironment remains a challenge and the development of novel tools that allow in vivo real time metabolic imaging and carbon flux analyses will promote innovative biological interventions and clinical evaluations. The identification and exploitation of the metabolic pathways regulating the function of T lymphocytes as well as other immune subsets will be critical for the development of new therapeutic strategies targeting tumors, infections, and autoimmune diseases. 
